Literature DB >> 19289416

L-FABP directly interacts with PPARalpha in cultured primary hepatocytes.

Heather A Hostetler1, Avery L McIntosh, Barbara P Atshaves, Stephen M Storey, H Ross Payne, Ann B Kier, Friedhelm Schroeder.   

Abstract

Although studies with liver type fatty acid binding protein (L-FABP) gene ablated mice demonstrate a physiological role for L-FABP in hepatic fatty acid metabolism, little is known about the mechanisms whereby L-FABP elicits these effects. Studies indicate that L-FABP may function to shuttle lipids to the nucleus, thereby increasing the availability of ligands of nuclear receptors, such as peroxisome proliferator-activated receptor-alpha (PPARalpha). The data herein suggest that such mechanisms involve direct interaction of L-FABP with PPARalpha. L-FABP was shown to directly interact with PPARalpha in vitro through co-immunoprecipitation (co-IP) of pure proteins, altered circular dichroic (CD) spectra, and altered fluorescence spectra. In vitro fluorescence resonance energy transfer (FRET) between Cy3-labeled PPARalpha and Cy5-labeled L-FABP proteins showed that these proteins bound with high affinity (Kd approximately 156 nM) and in close proximity (intermolecular distance of 52A). This interaction was further substantiated by co-IP of both proteins from liver homogenates of wild-type mice. Moreover, double immunogold electron microscopy and FRET confocal microscopy of cultured primary hepatocytes showed that L-FABP was in close proximity to PPARalpha (intermolecular distance 40-49A) in vivo. Taken together, these studies were consistent with L-FABP regulating PPARalpha transcriptional activity in hepatocytes through direct interaction with PPARalpha. Our in vitro and imaging experiments demonstrate high affinity, structural molecular interaction of L-FABP with PPARalpha and suggest a functional role for L-FABP interaction with PPARalpha in long chain fatty acid (LCFA) metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289416      PMCID: PMC2724054          DOI: 10.1194/jlr.M900058-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

3.  Statistical evaluation of colocalization patterns in immunogold labeling experiments.

Authors:  A A Philimonenko; J Janácek; P Hozák
Journal:  J Struct Biol       Date:  2000-12       Impact factor: 2.867

4.  Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with Co-factors.

Authors:  M Elholm; I Dam; C Jorgensen; A M Krogsdam; D Holst; I Kratchmarova; M Gottlicher; J A Gustafsson; R Berge; T Flatmark; J Knudsen; S Mandrup; K Kristiansen
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

5.  Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liver cells.

Authors:  M Elholm; A Garras; S Neve; D Tornehave; T B Lund; J Skorve; T Flatmark; K Kristiansen; R K Berge
Journal:  J Lipid Res       Date:  2000-04       Impact factor: 5.922

6.  Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat.

Authors:  W Engels; M van Bilsen; B H Wolffenbuttel; G J van der Vusse; J F Glatz
Journal:  Mol Cell Biochem       Date:  1999-02       Impact factor: 3.396

7.  Expression and intracellular processing of the 58 kDa sterol carrier protein-2/3-oxoacyl-CoA thiolase in transfected mouse L-cell fibroblasts.

Authors:  B P Atshaves; A D Petrescu; O Starodub; J B Roths; A B Kier; F Schroeder
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

8.  Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.

Authors:  C Wolfrum; C M Borrmann; T Borchers; F Spener
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

9.  Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus.

Authors:  J W Lawrence; D J Kroll; P I Eacho
Journal:  J Lipid Res       Date:  2000-09       Impact factor: 5.922

10.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.

Authors:  N Sreerama; R W Woody
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

View more
  73 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

2.  Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding.

Authors:  Angela M Gajda; Yin Xiu Zhou; Luis B Agellon; Susan K Fried; Sarala Kodukula; Walter Fortson; Khamoshi Patel; Judith Storch
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

3.  Stearic Acid Induces CD11c Expression in Proinflammatory Macrophages via Epidermal Fatty Acid Binding Protein.

Authors:  Jun Zeng; Yuwen Zhang; Jiaqing Hao; Yanwen Sun; Shujun Liu; David A Bernlohr; Edward R Sauter; Margot P Cleary; Jill Suttles; Bing Li
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

4.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

5.  Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner.

Authors:  Maria L R Hughes; Bonan Liu; Michelle L Halls; Kylie M Wagstaff; Rahul Patil; Tony Velkov; David A Jans; Nigel W Bunnett; Martin J Scanlon; Christopher J H Porter
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

6.  Two fatty acid-binding proteins expressed in the intestine interact differently with endocannabinoids.

Authors:  May Poh Lai; Francine S Katz; Cédric Bernard; Judith Storch; Ruth E Stark
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 7.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

8.  Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.

Authors:  Yun Zhang; Kechun Liu; Hozeifa M Hassan; Hongli Guo; Pingping Ding; Liwen Han; Qiuxia He; Weiyun Chen; Chung-Der Hsiao; Luyong Zhang; Zhenzhou Jiang
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

9.  Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice.

Authors:  Avery L McIntosh; Barbara P Atshaves; Danilo Landrock; Kerstin K Landrock; Gregory G Martin; Stephen M Storey; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

10.  Fatty acid binding proteins have the potential to channel dietary fatty acids into enterocyte nuclei.

Authors:  Adriana Esteves; Anja Knoll-Gellida; Lucia Canclini; Maria Cecilia Silvarrey; Michèle André; Patrick J Babin
Journal:  J Lipid Res       Date:  2015-12-11       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.